Which Healthcare ETF Is the Better Buy: State Street’s Pharma Fund XPH or iShares’ Biotech Fund IBB?

Key PointsState Street SPDR S&P Pharmaceuticals ETF has a lower expense ratio and a higher trailing dividend yield.

Read the full Veytics brief

We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.